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We have previously shown that angiomotin (Amot) plays an important role in growth factor-induced migration of endothelial cells in vitro.
Genetic knock-down of Amot in zebrafish also results in inhibition of migration of intersegmental vessels in vivo. Amot is expressed as two different
isoforms, p80-Amot and p130-Amot. Here we have analyzed the expression of the two Amot isoforms during retinal angiogenesis in vivo and
demonstrate that p80-Amot is expressed during the migratory phase. In contrast, p130-Amot is expressed during the period of blood vessel
stabilization and maturation. We also show that the N-terminal domain of p130-Amot serves as a targeting domain responsible for localization of
p130-Amot to actin and tight junctions. We further show that the relative expression levels of p80-Amot and p130-Amot regulate a switch between a
migratory and a non-migratory cell phenotype where the migratory function of p80-Amot is dominant over the stabilization and maturation function
of p130-Amot. Our data indicates that homo-oligomerization of p80-Amot and hetero-oligomerization of both isoforms are critical for this regulation.
© 2007 Elsevier B.V. All rights reserved.Keywords: Actin; Angiogenesis; Calcium switch; Retina; Tight junction1. Introduction
Angiogenesis is a process involving the formation of new
blood vessels by sprouting from pre-existing vessels and occurs
during embryogenesis, organ growth and other physiological
settings. Dysregulated blood vessel formation contributes to the
pathogenesis of many diseases including diabetic retinopathy,
atherosclerosis, endometriosis and tumor progression [1,2].
We previously identified angiomotin (Amot) by its binding
to the angiogenesis inhibitor angiostatin [3]. Amot is primarily
expressed by endothelial cells (ECs) but is also expressed by
epithelial structures such as the branchial arches and Rathke's
pouch in the developing mouse embryo [4]. Amot plays a
critical role in physiological angiogenesis during zebrafish
and mouse embryogenesis. For instance, knock-down of Amot
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mice exhibit vascular defects in the intersomitic vessels, dilated
vessels in the brain and die between E11 and 11.5 [4]. In
addition, targeting Amot with a DNA vaccination strategy
inhibits pathological angiogenesis and tumor growth in BALB/
C mice [5].
Amot is characterized by a conserved coiled-coil domain and
a C-terminal PDZ-binding motif [6], and is expressed as two
different isoforms, i.e. p80-Amot and p130-Amot. The longer
isoform, i.e. p130-Amot, contains an extended N-terminal
domain. These two isoforms possess distinct functions in vitro
where the shorter p80-Amot isoform enhances cell migration
and the longer p130-Amot isoform associates with actin and
affects cell shape [3,7,8].
Recent data demonstrated that Amot binds to Rich1, a Rho
GTPase activating protein (GAP), and to a protein complex
containing the PDZ-domain proteins Pals1, Patj, and Par-3 at
tight junctions [9].
In this study we demonstrate that the p80 and p130 Amot
isoforms are differentially expressed during specific stages of
mouse retina vascularization. We also provide evidence that
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oligomerization with p130-Amot, and speculate that this
mechanism regulates the switch between the migratory cell
phenotype induced by p80-Amot and the non-migratory cell
phenotype induced by p130-Amot.
2. Materials and methods
2.1. Cell lines and transfections
Chinese hamster ovary (CHO) cells, mouse aortic epithelial (MAE) cells and
Madin–Darby canine kidney (MDCK) cells were grown in Dulbecco's
Modified Eagle's Medium supplemented with 10% fetal bovine serum, glu-
tamine and antibiotics.
Cells were transfected with Lipofectamine 2000 according to the
manufacturer's protocol (Life Technologies).
2.2. Immunoprecipitation
Immunoprecipitation was performed as described previously [10]. Briefly,
cells were transfected as described above and 48 h later lyzed with lysis buffer
and centrifuged. The supernatant was pre-cleared and incubated with the
appropriate antibody for 6 h followed by incubation with sepharose A. Pellets
were washed with lysis buffer, re-suspended in 1x sample buffer and analyzed
by Western blot.
2.3. Protein extraction and Western blot
Western blots were performed as described previously [8]. For extraction of
total mouse retinal proteins, eyes were fixed for 3–5 min at RT in 4%
paraformaldehyde and rinsed in PBS. Retinas were dissected as previously
described [10] and homogenized in lysis buffer (1% Triton X-100, 1%
deoxycholic acid, 50 mM Tris (pH 8.0), 100 mM NaCl, 5 mM EDTA). Bands
present on Western blots were quantified using Image J 1.33 software (National
Institutes of Health, USA).
2.4. Immunofluorescence
Cultured cells were plated in chamber slides and stained as described
previously [8]. The stained cells were viewed using a Zeiss Axioplan 2
microscope, and images collected using an AxioCam HRm Camera and the
Axiovision 4.5 software. The confocal images were collected using a Leica SP5
DMI6000 microscope and the Leica microsystem LAS AF TCS SO5 software.
The images were then analyzed using the Image J 1.33 software.
For Amot staining in the mouse retina, eyes were removed, fixed in 4%
paraformaldehyde at 4 °C for 2–3 h, washed in PBS and the retinas dissected as
described above. Retinas were incubated for 2 h in PBB buffer (PBS containing
1% BSA, 0.5% Triton X-100 and 5% goat serum) and incubated at 4 °C
overnight with C-terminal Amot antibodies. After washing, retinas were
incubated for 2 h with FITC-conjugated swine anti-rabbit antibody (Dako
#F0205, Sweden) in PBS containing 0.5% BSA, 0.25% Triton X-100 and 5%
goat serum. The retinal vasculature was stained in whole mount retina according
to the protocol published by Gerhardt et al. [11].
2.5. Antibodies
Amot antibodies raised against the C-terminal of both p80-Amot and p130-
Amot were generated as described [8]. Antibodies and reagents used for
immunofluorescent staining were ZO-1 (Zymed), E-cadherin and CD31 (BD
Transduction Laboratories), phalloidin (Molecular Probes), and isolectin (Sigma
Chemical Co.). Secondary antibodies were purchased from Dako, Vector and
Molecular Probes. Antibodies used for Western blots were myc-tag (clone 9E10
from Santa Cruz), Flag (Sigma Chemical Co.), GST (Santa Cruz), and actin
(Sigma Chemical Co.). HRP-conjugated secondary antibodies were purchased
from Amersham.2.6. Migration assay
Migration assays were performed in a modified Boyden chamber using a 48-
well chemotaxis chamber (Neuroprobe Inc.) as described previously [3,8].
2.7. Calcium switch experiments
MDCK cells were transfected with different constructs 24 h before the
experiments. The cells were grown in calcium-free medium with 7 mM EGTA
for 1.5 h to dissociate cell–cell contacts. At different time points after re-addition
of calcium rich medium (i.e. 0, 1, 3, 6 and 16 h), cells were prepared for
immunostaining.
2.8. Statistical analysis
The Student t-test was used to determine statistical significance between
control and treatment groups. All analyses were performed using Statview 5.0.1
where ⁎⁎⁎, Pb0.001, ⁎⁎, Pb0.01 and ⁎, Pb0.05.
3. Results and discussion
3.1. The Amot isoforms are differently expressed during
angiogenesis
Our previous results indicate that the two Amot isoforms
play distinct roles during angiogenesis. For instance, p80-Amot
affects cell migration [3] whereas p130-Amot affects cell shape
[8]. To investigate their respective roles in vivo, we examined
their expression pattern during retinal angiogenesis.
The retinal vascular network develops postnatally and begins
as a sprout from the optic disc which forms a primitive vascular
plexus that is then rapidly remodeled and matures [12,13]. This
process is well characterized, and it is known precisely when
each of the different angiogenic events occur [11]. Therefore,
retinal angiogenesis in neonatal mice provides a valuable in
vivo model system for investigating the various events of
angiogenesis. However, very little is known of the mechanisms
responsible for the switch that causes ECs to stop migrating and
instead stabilize and mature.
Retinas from postnatal days (P) 3 and 7 were stained with
isolectin B4 that binds to ECs (Fig. 1A). Between P1 and P5,
ECs proliferate and migrate towards the periphery of the retina,
thus forming the initial vascular plexus (Fig. 1A). At P7, the
blood vessels reached the periphery of the retina and most of the
ECs shift from migration and undergo an active phase of
stabilization, maturation and differentiation (Fig. 1A). Positive
Amot staining was detected in the retina where it co-localized
with the endothelial specific marker CD31 (Fig. 1A), illustrat-
ing that Amot is expressed by the ECs during retinal
angiogenesis.
Retinas from different postnatal stages were dissected and
Amot isoform expression analyzed by Western blot. Only p80-
Amot was clearly expressed between P3 and P5 (Fig. 1B), and
still weakly expressed at P7. However, the predominant isoform
expressed after P7 was p130-Amot (Fig. 1B). In the adult mouse
retina, where blood vessels are mature and stabilized, only
p130-Amot was expressed (Fig. 1B). Thus P7, which cor-
responds to the time point where blood vessels have reached
the periphery of the retina, represents a critical time point when
Fig. 1. The Amot isoforms are differently expressed during mouse retinal angiogenesis. A. Flat-mount retinas stained with isolectin-B4 at postnatal days (P) 1 and 7.
Amot is expressed in ECs in the retina as shown in the merge image where it co-localizes with CD31. Scale bar: 100 μm. Photos from P3 and P7 are taken with the
same magnification. B. Western blot analysis using Amot antibodies demonstrates that p80-Amot and p130-Amot are differently expressed in the developing and adult
retina. Retinas were dissected from newborn mice (P1, 3, 5, 7 and 9) and adult mice (Ad). An unidentified band at 100 kDa was also detected at P7 and P9.
C. Quantification of Western blots (representative image illustrated in panel B) reveals the proportion of the two Amot isoforms at each time point of developing and
adult mouse retinas. D. Western blot analysis of MAE cells stably transfected with empty vector, p80-Amot and p130-Amot using Amot antibodies. For p130-Amot,
three different clones (c) were used (c1, c2 and c3) that express different amounts of p80-Amot. The graph below indicates the relative expression levels of each Amot
isoform compared to the total amount of Amot. E. Cells characterized in panel D were analyzed in Boyden chamber assays to determine their relative migration rates
compared to vector infected cells (red line). The migration experiments have been repeated at least three times with similar results. In the figure, one representative
experiment is shown.
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and mature profile. Our data indicate that Amot may be a crucial
mediator of this transition.
In support of this tenet, quantification of our in vivo data
demonstrated that p80-Amot is expressed in the retina during
the early phase of blood vessel formation, when the major
function of ECs is to migrate, and p130-Amot is expressed
during the stabilization and maturation of the blood vessels
(Fig. 1B). This data reveals that the relative expression levels of
the specific Amot isoforms (Fig. 1C) correlate well with their
proposed functions in the postnatal vascularization events in themouse retina and highlights that the two isoforms of Amot play
distinct roles during this process. We therefore proceeded to
comprehensively investigate the roles of the Amot isoforms in
vitro.
3.2. p80-Amot induces migration in p130-Amot expressing
cells
In order to investigate the relative p80-Amot expression
levels required to induce migration, MAE cells were utilized in
vitro. MAE cells are spontaneously immortalized ECs that do
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ted with p80-Amot or p130-Amot alone to investigate the
individual functions of the two isoforms [3,8]. MAE cells stably
infected with p130-Amot also express small amounts of p80-
Amot. We have previously reported that the p130-Amot
sequence does not contain any potential proteolytic cleavage
sites that could mediate the conversion of p130-Amot to p80-
Amot [8], indicating that the p130-Amot open reading frame
produces both isoforms.
We generated three MAE cell clones infected with p130-
Amot that expressed either 10% p80-Amot compared to p130-
Amot (clone 1), 5% p80-Amot (clone 2) or only p130-Amot
(clone 3) (Fig. 1D). As controls, MAE cells infected with p80-
Amot or empty vector were used. The capacity of the cells to
migrate was tested multiple times in a Boyden chamber assay
where the cells were allowed to migrate towards bFGF. As
illustrated in Fig. 1E (one representative experiment), clone 3,
which expressed only p130-Amot exhibited a significant
decrease in migration of approximately 50% compared to vector
cells. Interestingly, clone 2, which expresses 5% p80-Amot
compared to p130-Amot, exhibited approximately the same
migratory rate as vector cells. Furthermore, clone 1, which
expresses 10% p80-Amot compared to p130-Amot, exhibited a
similar migratory rate to that of p80-Amot only-expressing cells,
with a significant two-fold increase in migration compared to
vector transfected cells. Since a ratio of 1:10 p80-Amot:p130-
Amot favors p80-Amot function, this data suggests that if ECs
express only p130-Amot, migration will be repressed, whereas a
relatively small amount of p80-Amot is sufficient to dominate
EC function and induce a migratory phenotype.
3.3. p80-Amot induces a migratory phenotype in MDCK cells
MDCK cells are epithelial cells derived from the distal
tubules of canine kidney and widely used for studies of
epithelial cell polarity and cell junctions.
p80-Amot has been shown to play a role in cell polarization
[9] and both Amot isoforms have been shown to localize to
cell–cell contacts [9,14]. We used MDCK cells that do not
express any isoform of endogenous Amot (determined by
Western blot and immunofluorescence, data not shown) to
investigate the localization of transfected p80-Amot, p130-
Amot and the N-terminal domain of p130-Amot (Fig. 2A). We
also transfected MDCK cells with constructs of p80-Amot and
p130-Amot lacking the last three amino acids in their C-ter-
minal PDZ-binding domain (ΔPDZ-bind) (Fig. 2A) which has
been shown to inhibit the migratory function of p80-Amot in
previous studies [7].
We demonstrated that p80-Amot is highly expressed in
MDCK cells that appear migratory (Fig. 2C). The p80-Amot
expressing cells displayed extensions, lamellipodia (Fig. 2G)
and a different morphology compared to the other, non-
transfected polarized MDCK cells that exhibited regular tight
junctions. This change in morphology was also found in p80-
Amot expressing cells in contact with other p80-Amot
expressing cells (S Fig. 1A). In addition, weak expression of
p80-Amot was detected in cell–cell contacts (Fig. 2B).Staining of MDCK cells transfected with p130-Amot re-
vealed that p130-Amot localized to cell–cell contacts, re-
gardless of whether neighboring cells expressed p130-Amot
(Fig. 2D) or not (S Fig. 1B). In addition, p130-Amot was
found to be expressed in a vesicular pattern, as previously
shown [8]. In contrast to the expression of p80-Amot, the
expression of p130-Amot did not change the cell morphology
towards a migratory phenotype. MDCK cells were also trans-
fected with the p130-Amot N-terminal domain, resulting in
expression in cell–cell contacts and in the edges of the cells
where it co-localized with actin (Fig. 2E). The N-terminal
fragment also overlapped with actin fibers (S Fig. 1C), as
previously demonstrated in MAE cells [8], indicating that the
N-terminal domain of p130-Amot co-localizes to actin in sev-
eral cell types.
Cells transfected with p80ΔPDZ-bind exhibited cytoplasmic
expression of p80-Amot in the absence of cell–cell contacts
(S Fig. 1D) whereas cells transfected with p130ΔPDZ-bind
exhibited an identical staining pattern compared to p130-Amot
transfected cells (S Fig. 1E).
These results demonstrate that p80-Amot expression induces
a migratory cell phenotype characterized by extensions and
lamellipodia whereas expression of p130-Amot, or its N-ter-
minal domain, at cell–cell contacts in association with actin
does not change the cell morphology towards a migratory
phenotype. To quantify the frequency with which p80-Amot
over expression results in a migratory phenotype, we deter-
mined the number of migratory cells present following
transfection with p80-Amot, p130-Amot or GFP (S Fig. 1F).
As illustrated in Fig. 2F, 52% of cells expressing p80-Amot
were migratory compared to only 30% of GFP expressing cells
and 20% of p130-Amot expressing cells.
In contrast to p80-Amot, this data suggests that p130-Amot
is not dependent on its PDZ-binding domain for tight junction
localization. Instead, its N-terminal domain appears to be a
critical targeting domain for localization. These findings are
consistent with the temporal expression of Amot observed in
vivo where p80-Amot is predominantly expressed during the
migratory phase of angiogenesis and p130-Amot is primarily
expressed during the blood vessel stabilization phase.
3.4. The N-terminal domain of p130-Amot directs localization
to tight junctions
To explore the respective roles of the different angiomotin
isoforms during cell–cell contact formation, we examined the
localization of p80-Amot, p130-Amot, the specific p130-Amot
N-terminal domain, p80ΔPDZ-bind and p130ΔPDZ-bind in
MDCK cells during polarization and cell–cell contact forma-
tion. In low calcium medium, the tight junctions in MDCK cells
were disrupted, the cells became unpolarized and the Amot
isoforms and mutants concentrated in the cytoplasm where they
co-localized with ZO-1 (i.e. p80-Amot, p80ΔPDZ-bind, p130-
Amot and p130ΔPDZ-bind) or phalloidin (i.e. N-terminal
domain) (S Fig. 2A, B).
We then examined the localization of the constructs at 1 h,
3 h, 6 h and 16 h after re-addition of calcium. MDCK cells
Fig. 2. p80-Amot and p130-Amot exhibit distinct localization patterns in MDCK cells. A. The Amot constructs used for transfection of MDCK cells. B. MDCK cells
transfected with p80-Amot were double stained with Amot antibodies (green) and Texas red-conjugated phalloidin (red) and show that the p80-Amot isoform localizes to
cell–cell contacts. C. The same staining regime utilized in panel B of MDCK cells demonstrated that some p80-Amot expressing cells display a migratory phenotype with
several extensions. D. The same staining regime utilized in panel B of MDCK cells transfected with p130-Amot illustrates cell–cell contact staining. E. MDCK cells
transfected with a flag-tagged construct encoding the N-terminal domain of p130-Amot and stained with flag antibody and phalloidin show that the N-terminus co-localizes
with actin. Scale bar, 20 μm. F. The relative proportions of migratory MDCK cells following transfection with GFP, p80-Amot or p130-Amot were calculated. 31% of GFP
expressing cells (n=453), 52% of p80-Amot expressing cells (n=398) and 21% of p130-Amot expressing cells (n=368) exhibited migratory phenotypes. G. p80-Amot
transfe cted cells form lamellipodia s. Scale bar, 10 μm.
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calcium re-addition as indicated by ZO-1 staining in Fig. 3A.
However, the cells that expressed p80-Amot showed a mi-gratory phenotype that sometimes lacked the cell–cell con-
tacts and instead formed extensions. This was also observed
after 3 h, 6 h and 16 h (Fig. 3 and S Fig. 2A). However, after
Fig. 4. p80-Amot forms homo-oligomers and hetero-oligomers with p130-Amot and p80-Amot expression results in translocation of p130-Amot away from cell–cell
contacts. A. CHO cells transfected with myc-p80-Amot and flag-p80-Amot homo-oligomerize as shown by immunoprecipitation followed by Western blot. B. p80-
Amot and p130-Amot hetero-oligomerize as shown by immunoprecipitation using GST-p130-Amot and myc-p80-Amot. C. Co-transfection of GST-p130-Amot and
p80-Amot results in translocation of p130-Amot from cell–cell contacts to vesicles in the cytoplasm.
435M. Ernkvist et al. / Biochimica et Biophysica Acta 1783 (2008) 429–43716 h, the cell–cell contact localization of p80-Amot observed in
non-treated cells started to reappear (Fig. 3A). A similar pattern
of expression was observed for p80ΔPDZ-bind (Fig. 3A and S
Fig. 2A), with the exception that p80ΔPDZ-bind was not
localized to cell–cell contacts. These data indicate that p80-
Amot expressing cells initiate migration at a stage when contact
is lost with their surrounding cells.
p130-Amot was expressed at cell–cell contacts rapidly, i.e.
within 1 h after calcium re-addition (Fig. 3B and S Fig. 2B) and
no changes in cell morphology were observed. A similar pattern
of expression was observed for p130ΔPDZ-bind expressing
cells (Fig. 3B, S Fig. 2B).
The removal and re-addition of calcium demonstrated that,
after re-addition of calcium, the N-terminal domain was closely
associated with the dynamics of actin. This is illustrated by the
observation that the N-terminal domain co-localized with actin
rapidly, i.e. within 1 h, following culture in calcium rich
medium (Fig. 3B).
These results imply that the N-terminal domain of p130-
Amot contains a targeting domain that causes localization of
p130-Amot to actin early in the process of cell–cell contact
formation and that p130-Amot does not stimulate a migratoryFig. 3. The PDZ-binding domain is not an important targeting domain for p130-Amot
to calcium removal and re-addition at different time points (1 h, 3 h, and 16 h) followe
Amot, p130ΔPDZ-bind and the N-terminal domain were subjected to calcium remova
and ZO-1 or the N-terminal domain and phalloidin. Scale bar, 20 μm. C. Confocal m
Amot only partly co-localizes with ZO-1. The arrows point at the areas that were look
Amot co-localizes with E-cadherin. In contrast, p80-Amot exhibited no co-localization
Scale bar 10 μm.phenotype. p80-Amot, on the other hand, induces a migratory
phenotype and exhibits delayed localization to cell–cell con-
tacts compared to p130-Amot and ZO-1. Furthermore, the
localization of p80-Amot to cell–cell contacts is fully dependent
on its PDZ-binding domain, which is a distinctly different
targeting domain compared to that of p130-Amot. Instead, the
N-terminal domain of p130-Amot plays a crucial role in p130-
Amot function and is a more effective targeting domain than the
PDZ-binding domain since deletion of the PDZ-binding domain
has no effect on the function of p130-Amot.
To investigate if p80-Amot and p130-Amot exhibit different
patterns of localization along lateral cell–cell contacts, their
localization was analyzed by confocal microscopy and com-
pared to ZO-1 (tight junctions) and E-cadherin (adherent
junctions). Our data demonstrates that p130-Amot is expressed
at ZO-1 positive tight junctions (Fig. 3C) but is only partly co-
localized with E-cadherin (Fig. 3D), indicating that p130-Amot
is predominantly localized to tight junctions rather than adherent
junctions. p80-Amot exhibited a more diffuse localization,
largely as a result of its very weak cell–cell contact expression.
No p80-Amot was found in E-cadherin positive adherent
junctions (Fig. 3D). In contrast, some p80-Amot was expressed. A. MDCK cells transfected with p80-Amot and p80ΔPDZ-bind were subjected
d by immunostaining for Amot and ZO-1. B. MDCK cells transfected with p130-
l and re-addition at different time points (1 h, 3 h, and 16 h) and stained for Amot
icroscopy demonstrates that p130-Amot co-localizes with ZO-1 whereas p80-
ed at from the side. D. MDCK cells stained for E-cadherin show that some p130-
with E-cadherin. The arrows point at the areas that were looked at from the side.
436 M. Ernkvist et al. / Biochimica et Biophysica Acta 1783 (2008) 429–437at the positive ZO-1 tight junctions (Fig. 3C). These findings are
in accordance with previous published results [9,15].
3.5. p80-Amot forms homo-oligomers and hetero-oligomers
with p130-Amot
Both p80-Amot and p130-Amot contain a coiled-coil
domain [6]. Coiled-coil structures have been found in a number
of proteins with diverse functions and can play a role in
dimerization and also act as mediators of protein–protein
interactions. Therefore, we explored if the two Amot isoforms
homo-oligomerize or hetero-oligomerize.
First, we tested whether p80-Amot and/or p130-Amot could
homo-oligomerize. For this purpose we transfected CHO cells,
which do not express endogenous Amot [14], with tagged
constructs of p80-Amot or p130-Amot. As shown in Fig. 4A
(and in S Fig. 3A), p80-Amot forms homo-oligomers. In
contrast, no self-association of p130-Amot could be detected
(data not shown).
We then examined if p80-Amot and p130-Amot could
hetero-oligomerize. Analysis of CHO cells transfected with
GST-tagged p130-Amot and myc-tagged p80-Amot revealed
that p80-Amot and p130-Amot form hetero-oligomers (Fig. 4B
and S Fig. 3B).
These data show that p80-Amot can both homo-oligomerize
and hetero-oligomerize with p130-Amot. Such an event could
be responsible for the differential regulation of the two isoforms
during angiogenesis. We thus speculate that p80-Amot self-
association favors EC migration. Furthermore, one possible
mechanism for the regulation of a switch from p80-Amot to
p130-Amot or vice versa is the hetero-oligomerization of the
two isoforms.
3.6. p80-Amot causes translocation of p130-Amot from
cell–cell contacts to the cytoplasm
In order to understand the functional role of p80-Amot homo-
oligomers versus p80–p130 hetero-oligomers, MDCK cells
were transfected with tagged constructs of p80-Amot and p130-
Amot and their localization investigated. When GST-p130-
Amot and flag-p80-Amot were co-transfected at a ratio of 1:1,
the cell–cell contact localization of GST-p130-Amot (S Fig. 4C)
was lost and translocated to vesicles in the cytoplasm where it
co-localized with flag-p80-Amot (Fig. 4C). We also transfected
GST-p130-Amot and flag-p80-Amot in a ratio of 10:1 of p130-
Amot:p80-Amot to mimic the expression levels of MAE cell
clones where only a relatively small amount of p80-Amot
compared to p130-Amot was enough to induce a migratory
phenotype. Although some GST-p130-Amot still localized to
cell–cell contacts, most of the protein was found to be expressed
in a dispersed pattern in the cytoplasm together with p80-Amot
(S Fig. 4A). Double transfection of flag-p80-Amot and myc-
p80-Amot demonstrated a similar expression pattern to that
when p80-Amot was transfected alone (S Fig. 4B, D). These
results indicate that p80-Amot has a migratory function that is
dominant over p130-Amot and that p80-Amot expression results
in translocation of p130-Amot away from its tight junctionlocalization, thereby inhibiting the stabilizing function of p130-
Amot.
In summary, these data indicate that the two isoforms of the
same protein play divergent roles during blood vessel formation
and that the hetero-oligomerization of p80-Amot and p130-
Amot allows p80-Amot to regulate the function of p130-Amot.
All together, these data indicate that the two isoforms of the
same protein play different roles during blood vessel formation
and the hetero-oligomerization data imply that p80-Amot
regulate the function of p130-Amot.
3.7. Speculation
Taken together, these data imply that p80-Amot induces
EC migration during angiogenesis. In contrast, p130-Amot
appears to play a role in the later phase of angiogenesis when
stabilization and maturation are important. We believe that the
N-terminal domain of p130-Amot binds to a complex of proteins
important for its localization and function, which are distinct
from that of p80-Amot.
Our results indicate that the two Amot isoforms play distinct
roles during angiogenesis. We propose that p80-Amot can
induce a migratory phenotype in stabilized vessels by hetero-
oligomerization to p130-Amot. Although little is understood of
the mechanisms underlying the switch from migrating cells to
stabilized cells, we present evidence here that two isoforms of
the same protein could play an important role in regulating such
a switch.
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